Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GLMD

Galmed Pharmaceuticals Ltd

May 08 • 09:52AM ET

0.6300

+0.0035 0.57 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: IMNN PALI SABS TNXP BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.33	Insider Own	3.70%	Shs Outstand	6.58M	Perf Week	10.31%
Market Cap	4.15M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	0.00%	Shs Float	6.36M	Perf Month	-19.77%
Enterprise Value	-14.13M	PEG	-	EPS next Q	-0.38	Inst Own	6.00%	Short Float	7.90%	Perf Quarter	-5.11%
Income	-10.31M	P/S	-	EPS this Y	34.73%	Inst Trans	3.53%	Short Ratio	0.17	Perf Half Y	-48.78%
Sales	0.00M	P/B	0.26	EPS next Y	42.31%	ROA	-55.53%	Short Interest	0.50M	Perf YTD	-16.06%
Book/sh	2.40	P/C	0.23	EPS next 5Y	31.74%	ROE	-64.21%	52W High	2.34 -73.08%	Perf Year	-49.60%
Cash/sh	2.77	P/FCF	-	EPS past 3/5Y	73.46% 60.33%	ROIC	-65.32%	52W Low	0.41 53.25%	Perf 3Y	-99.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.27% 11.90%	Perf 5Y	-99.86%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	74.58%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-99.93%
Dividend Ex-Date	-	Quick Ratio	6.55	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.52	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.55	EPS Q/Q	62.02%	SMA20	-3.37%	Beta	0.62	Target Price	12.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	1.42%	Rel Volume	0.03	Prev Close	0.63
Employees	6	LT Debt/Eq	0.00	Earnings	Apr 01	SMA200	-38.40%	Avg Volume	3.04M	Price	0.63
IPO	Mar 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	10,271	Change	0.57%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)